EP0689460A4 - Cyclobutyl antisense oligonucleotides, methods of making and use thereof - Google Patents
Cyclobutyl antisense oligonucleotides, methods of making and use thereofInfo
- Publication number
- EP0689460A4 EP0689460A4 EP93906159A EP93906159A EP0689460A4 EP 0689460 A4 EP0689460 A4 EP 0689460A4 EP 93906159 A EP93906159 A EP 93906159A EP 93906159 A EP93906159 A EP 93906159A EP 0689460 A4 EP0689460 A4 EP 0689460A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- methods
- making
- antisense oligonucleotides
- cyclobutyl
- cyclobutyl antisense
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 108020000948 Antisense Oligonucleotides Proteins 0.000 title 1
- 239000000074 antisense oligonucleotide Substances 0.000 title 1
- 238000012230 antisense oligonucleotides Methods 0.000 title 1
- 108091034117 Oligonucleotide Proteins 0.000 abstract 2
- 230000000692 anti-sense effect Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000003153 chemical reaction reagent Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 125000005647 linker group Chemical group 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
- C12N15/1133—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses against herpetoviridae, e.g. HSV
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1137—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y113/00—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13)
- C12Y113/11—Oxidoreductases acting on single donors with incorporation of molecular oxygen (oxygenases) (1.13) with incorporation of two atoms of oxygen (1.13.11)
- C12Y113/11012—Linoleate 13S-lipoxygenase (1.13.11.12)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/323—Chemical structure of the sugar modified ring structure
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1993/001579 WO1994019023A1 (en) | 1993-02-19 | 1993-02-19 | Cyclobutyl antisense oligonucleotides, methods of making and use thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0689460A1 EP0689460A1 (en) | 1996-01-03 |
EP0689460A4 true EP0689460A4 (en) | 1996-11-13 |
Family
ID=22236344
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP93906159A Withdrawn EP0689460A4 (en) | 1993-02-19 | 1993-02-19 | Cyclobutyl antisense oligonucleotides, methods of making and use thereof |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP0689460A4 (en) |
JP (1) | JPH08503957A (en) |
AU (1) | AU3729493A (en) |
WO (1) | WO1994019023A1 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0912767B1 (en) * | 1996-07-16 | 2006-09-13 | Gen-Probe Incorporated | Methods for detecting and amplifying nucleic acid sequences using modified oligonucleotides having increased target specific tm |
US7070925B1 (en) | 1996-07-16 | 2006-07-04 | Gen-Probe Incorporated | Method for determining the presence of an RNA analyte in a sample using a modified oligonucleotide probe |
US6025133A (en) * | 1996-12-30 | 2000-02-15 | Gen-Probe Incorporated | Promoter-sequestered oligonucleoside and method of use |
US6534273B2 (en) | 1997-05-02 | 2003-03-18 | Gen-Probe Incorporated | Two-step hybridization and capture of a polynucleotide |
EP0975807B1 (en) * | 1997-05-02 | 2006-09-27 | Gen-Probe Incorporated | Two-step hybridization and capture of a polynucleotide |
EP1251181A1 (en) * | 2001-04-20 | 2002-10-23 | Warner-Lambert Company | Non-recombinant cell lines capable of expressing predominantly cyclic nucleotide phosphodiesterase 4 (PDE4) subtype B and their use for the screening of PDE4 subtype-specific modulators |
KR20100063144A (en) | 2004-02-18 | 2010-06-10 | 크로모셀 코포레이션 | Methods and materials using signaling probes |
CA2640080A1 (en) | 2006-02-02 | 2008-03-13 | Allergan, Inc. | Compositions and methods for the treatment of ophthalmic disease |
US11078262B2 (en) | 2007-04-30 | 2021-08-03 | Allergan, Inc. | High viscosity macromolecular compositions for treating ocular conditions |
CA2900852A1 (en) | 2013-03-15 | 2014-09-18 | Chromocell Corporation | Methods and materials using signaling probes |
US10669547B2 (en) | 2013-03-15 | 2020-06-02 | Kambiz Shekdar | Genome editing using effector oligonucleotides for therapeutic treatment |
CN106103463B (en) | 2014-02-18 | 2018-11-30 | 国立大学法人大阪大学 | Bridging type nucleosides and nucleotide |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5359044A (en) * | 1991-12-13 | 1994-10-25 | Isis Pharmaceuticals | Cyclobutyl oligonucleotide surrogates |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5087617A (en) * | 1989-02-15 | 1992-02-11 | Board Of Regents, The University Of Texas System | Methods and compositions for treatment of cancer using oligonucleotides |
-
1993
- 1993-02-19 JP JP6518919A patent/JPH08503957A/en active Pending
- 1993-02-19 EP EP93906159A patent/EP0689460A4/en not_active Withdrawn
- 1993-02-19 WO PCT/US1993/001579 patent/WO1994019023A1/en not_active Application Discontinuation
- 1993-02-19 AU AU37294/93A patent/AU3729493A/en not_active Abandoned
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5359044A (en) * | 1991-12-13 | 1994-10-25 | Isis Pharmaceuticals | Cyclobutyl oligonucleotide surrogates |
Non-Patent Citations (4)
Title |
---|
H.BOUMCHITA ET AL.: "New Cyclobutyl Analogues of Adenosine and Guanosine. Part 1. Synthesis of the 9-(3,3-Bis(hydroxymethyl)cyclobutyl)purine Nucleoside Analogs.", JOURNAL OF HETEROCYCLIC CHEMISTRY, vol. 27, no. 6, September 1990 (1990-09-01), PROVO US, pages 1815 - 1819, XP002002613 * |
H.BOUMCHITE ET AL.: "New Cyclobutyl Analogs of Nucleosides. Part 2. Synthesis and Antiviral Evaluation of 2-Amino-7-(3,3-bis(hydroxymethyl)cyclobut-1-yl)-3H,7H-pyrrolo-(2,3-d)pyrimidin-4-one and of Cyclobutyl Analogs of the Pyrimidine Nucleosides.", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRYCHIMICA THERAPEUTICA., vol. 26, no. 5, July 1991 (1991-07-01), PARIS FR, pages 613 - 617, XP002002614 * |
See also references of WO9419023A1 * |
T.MARUYAMA ET AL.: "Synthesis and Antiviral Activities of Carbocyclic Oxetanocin Analogues.", CHEMICAL AND PHARMACEUTICAL BULLETIN, vol. 38, no. 10, October 1990 (1990-10-01), JAPAN, pages 2719 - 2725, XP002002615 * |
Also Published As
Publication number | Publication date |
---|---|
JPH08503957A (en) | 1996-04-30 |
WO1994019023A1 (en) | 1994-09-01 |
EP0689460A1 (en) | 1996-01-03 |
AU3729493A (en) | 1994-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA964136B (en) | Catalytic DNA. | |
AU2580892A (en) | Determination of oligonucleotides for therapeutics, diagnostics and research reagents | |
CA2160016A1 (en) | Method of forming oligonucleotides | |
CA2153898A1 (en) | Method for generating single-stranded dna molecules | |
EP0909775A4 (en) | Catalyst for producing polyester, process for producing the same, and process for producing polyester by using the same | |
ZA9610687B (en) | Novel synthesis. | |
EP0623171A4 (en) | Enzymatic rna molecules. | |
ZA965019B (en) | Isothermal PCR. | |
EP1310507A3 (en) | Novel peptide nucleic acids | |
AU1884392A (en) | Peptide nucleic acids | |
EP0689460A4 (en) | Cyclobutyl antisense oligonucleotides, methods of making and use thereof | |
AU7196196A (en) | Copper-based catalysts, processes for their production and their use and a process for the production of alkyl halosilanes | |
EP0656070A4 (en) | Nucleic acid probes for bacteria of the genus legionella. | |
HUP9600325A3 (en) | Dna sequence of a. thaliana, delta-7-red protein, process for producing thereof, yeats strains transformed by this dna and use thereof | |
HUP0001923A3 (en) | Pesticidal 1-aryl-3-iminopyrazoles, process for their preparation, their use | |
AU675251B2 (en) | Flow-through hybridization assay for oligonucleotide sequences | |
ZA963642B (en) | Catalyst for vinyl acetate manufacture. | |
ZA963915B (en) | Obesity gene product. | |
ZA961082B (en) | DNA sequence. | |
EP0749439A4 (en) | Nucleotide or nucleoside photoaffinity compound modified antibodies, methods for their manufacture and use thereof | |
HK1056360A1 (en) | Process for preparing pesticidal intermediates. | |
GB2297328B (en) | Nucleic acid sequence encoding a human H2 receptor region, and oligonucleotide primers for amplification and sequencing thereof | |
AU6186398A (en) | Process for selecting anti-sense oligonucleotides | |
ZA966348B (en) | Process for preparing 1,4,8,11 - tetraazacyclotetradecane. | |
EP0748868A3 (en) | Ceramide glucosyltransferase |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 19950919 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
A4 | Supplementary search report drawn up and despatched |
Effective date: 19960926 |
|
AK | Designated contracting states |
Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: NOVARTIS AG Owner name: ISIS PHARMACEUTICALS, INC. |
|
17Q | First examination report despatched |
Effective date: 19980626 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20000922 |